skip to content
Primary navigation

Duavee

Drug - Duavee™ (conjugated estrogens/bazedoxifene) [Pfizer]

November 2014

Therapeutic area - Estrogen replacement/osteoporosis prevention

Approval criteria

  • Patient has tried and failed alendronate AND
  • Patient has tried and failed ibandronate AND 
  • Patient has tried and failed at least one oral or transdermal estrogen product 

Quantity limit

Quantity limit = 34 

Questions?

MHCP Provider Call Center 651-431-2700 or 800-366-5411

back to top